Aleksandra Rizo
Förmögenhet: 546 500 $ per 2026-06-30
Förmögenhet: 546 500 $ per 2026-06-30
Aleksandra Rizo is currently President, Chief Executive Officer & Director at Vividion Therapeutics, Inc. since 2023 and Independent Director at Syndax Pharmaceuticals, Inc. starting in 2024.
Former positions include Chief Medical Officer & Executive Vice President at Geron Corp.
from 2019 to 2022, Executive Director-Strategy & Clinical Leader at Celgene Corp.
from 2018 to 2019, and Senior Director & Team Leader Compound Development at Janssen Research & Development LLC from 2014 to 2018.
Education includes doctorates from the University of Groningen, the University of Tokyo, and Saints Cyril & Methodius University of Skopje.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-30 | 25 000 ( 0,03 % ) | 546 500 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2024-05-14 |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Verkställande Direktör | 2023-01-24 |
| Företag | Position | Slut |
|---|---|---|
| GERON CORPORATION | Teknisk/Vetenskaplig/F&U Direktör | 2022-07-08 |
| CELGENE | Företagsledare/Principal | 2019-01-01 |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Företagsledare/Principal | 2018-03-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Groningen
University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tokyo
University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Saints Cyril & Methodius University of Skopje
Saints Cyril & Methodius University of Skopje Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån